Research from the MRC Molecular Haematology Unit has revealed a protein called galectin-1 as a key marker for disease progression and as a promising therapeutic target for patients with myeloproliferative neoplasms (a type of blood cancer).
In a study published in the Journal of Clinical Oncology, an international research team has used machine learning to improve risk stratification for patients over 60 diagnosed with acute myeloid leukaemia, an aggressive type of blood cancer.
Patients who are being treated with systemic glucocorticoids are more than twice as likely to develop diabetes as those not receiving the treatment, a new study by researchers at the Radcliffe Department of Medicine\u2019s Diabetes Trial Unit has found.
World-leading cardiology experts are to convene at the annual European Society of Cardiology (ESC) Congress in London from tomorrow (Friday 30 August).
Congratulations to Professor Michael Zimmermann, who has been awarded the title of Full Professor in the University\u2019s 2024 Recognition of Distinction exercise.
Researchers from the MRC Weatherall Institute of Molecular Medicine (WIMM) have shown that blood stem cell subtypes found in mice also exist in humans. This provides important information for research into therapies to alleviate the negative effects of aging.
An expert group including Deborah Gill, Professor of Gene Medicine in RDM\u2019s Nuffield Division of Clinical Laboratory Sciences, has published a new position paper which addresses the gaps in research and treatment development for familial pulmonary fibrosis (FPF) \u2013 a collection of individually rare and severe genetically inherited lung diseases.
Congratulations to Professor Jeremy Tomlinson on winning an award for \u2018Outstanding Chief Investigator\u2019 from the National Institute of Health and Care Research\u2019s (NIHR) Thames Valley and South Midlands Clinical Research Network (LCRN).
On Monday 22 July, Professor Vanessa Ferreira gave her inaugural lecture titled, The investigation of cardiovascular diseases using MRI parametric mapping: The Past, Present and Future.
Semaglutide \u2013 widely known as Ozempic or Wegovy \u2013 does not appear to negatively impact brain health and is associated with lower risk of cognitive problems and less nicotine dependence, according to a new study.
Yellowstone Biosciences, a biotechnology spinout, has launched to pioneer new cancer treatments using advanced T-cell therapies based on groundbreaking research from the MRC Weatherall Institute of Molecular Medicine at the University of Oxford.
Congratulations to RDM\u2019s Professor Rajesh Vasantlal Thakker FRS, May Professor of Medicine and lately President, Society for Endocrinology, who has been appointed Officer of the Order of the British Empire (OBE) in the King\u2019s Birthday Honours 2024.
Thousands of patients admitted to hospital every year with suspected heart attacks could avoid an unnecessary invasive procedure if they have a routine heart MRI scan first, according to research led by the Radcliffe Department of Medicine.
A research team led by scientists at the Radcliffe Department of Medicine, University of Oxford has developed an Artificial Intelligence (AI) technology which can accurately predict the risk of a heart attack, heart failure or cardiac death from routine cardiac CT scans, up to ten years in advance.
![\"Exemplar](\"https://www.rdm.ox.ac.uk/news/galectin-1-mpns/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n